SEC Filing Update: #SABS SAB Biotherapeutics, Inc. : $3.87

Sector: Healthcare | YTD: 🔼+ 3.20% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #SABS Shares by 41.96% 🟢 * Previous Holdings: 5.09M Shares * Current Holdings: 7.23M Shares * Increase+2.14M * Increased(%)+41.96% * Ownership: 9.45% * Estimated Investment Value: $8.16M https://www.thinksabio.com/reports/isr/SABS Institutional ownership in #SABS has been steadily rising over the past 4 quarters in Shares: Q2 2025: 1.92M Q3 2025: 28.02M Q4 2025: 36.34M Q1 2026: 69.19M 📌 Institutional activity in the last 30 days for #SABS: • RA CAPITAL MANAGEMENT – Increased holdings by 5,208,352 shares (10-AUG-2026) • Adage Capital Management, L.P. – Newly bought 6,405,553 shares (12-AUG-2026)